Guidance for the Treatment and Management ofCOVID-19 Among People with Intellectual Disabilities

被引:55
|
作者
Alexander, Regi [1 ,2 ]
Ravi, Ambiga [3 ]
Barclay, Helene [1 ]
Sawhney, Indermeet [4 ]
Chester, Verity [1 ]
Malcolm, Vicki [1 ]
Brolly, Kate [1 ]
Mukherji, Kamalika [5 ]
Zia, Asif [5 ]
Tharian, Reena [6 ,7 ]
Howell, Andreana [8 ]
Lane, Tadhgh [8 ]
Cooper, Vivien [9 ]
Langdon, Peter E. [10 ,11 ,12 ]
机构
[1] Hertfordshire Partnership Univ NHS Fdn Trust, Little Plumstead Hosp, Norwich, Norfolk, England
[2] Univ Hertfordshire, Hatfield, Herts, England
[3] Hertfordshire Partnership Univ NHS Fdn Trust, Bowlers Green, Hatfield, Herts, England
[4] Hertfordshire Partnership Univ NHS Fdn Trust, Lexden Hosp, Colchester, Essex, England
[5] Hertfordshire Partnership Univ NHS Fdn Trust, Hatfield, Herts, England
[6] Hellesdon Hosp, Norwich, Norfolk, England
[7] Suffolk NHS Fdn Trust, Norwich, Norfolk, England
[8] Res Dev NeuropsychiaT RADiANT, Norwich, Norfolk, England
[9] Challenging Behav Fdn, Chatham, Kent, England
[10] Univ Warwick, CEDAR, Coventry CV4 7AL, W Midlands, England
[11] Worcestershire Hlth & Care NHS Trust, Worcester, MA USA
[12] Coventry & Warwickshire Partnership NHS Trust, Coventry, W Midlands, England
关键词
coronavirus; intellectual disabilities; learning disabilities; neurodevelopmental disorders; SARS-CoV-2; COVID-19; MENTAL-RETARDATION; HEALTH; ADULTS; MORTALITY; PREVALENCE; CARE;
D O I
10.1111/jppi.12352
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The current COVID-19 pandemic is a pressing world crisis and people with intellectual disabilities (IDs) are vulnerable due to disparity in healthcare provision and physical and mental health multimorbidity. While most people will develop mild symptoms upon contracting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), some will develop serious complications. The aim of this study is to present guidelines for the care and treatment of people with IDs during the COVID-19 pandemic for both community teams providing care to people with IDs and inpatient psychiatric settings. The guidelines cover specific issues associated with hospital passports, individual COVID-19 care plans, the important role of families and carers, capacity to make decisions, issues associated with social distancing, ceiling of care/treatment escalation plans, mental health and challenging behavior, and caring for someone suspected of contracting or who has contracted SARS-CoV-2 within community or inpatient psychiatric settings. We have proposed that the included conditions recommended by Public Health England to categorize someone as high risk of severe illness due to COVID-19 should also include mental health and challenging behavior. There are specific issues associated with providing care to people with IDs and appropriate action must be taken by care providers to ensure that disparity of healthcare is addressed during the COVID-19 pandemic. We recognize that our guidance is focused upon healthcare delivery in England and invite others to augment our guidance for use in other jurisdictions.
引用
收藏
页码:256 / 269
页数:14
相关论文
共 50 条
  • [1] Clinical presentation and management ofCOVID-19
    Thevarajan, Irani
    Buising, Kirsty L.
    Cowie, Benjamin C.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 213 (03) : 134 - 139
  • [2] Treatment ofCOVID-19 with pentoxifylline: Could it be a potential adjuvant therapy?
    Seirafianpour, Farnoosh
    Mozafarpoor, Samaneh
    Fattahi, Nima
    Sadeghzadeh-Bazargan, Afsaneh
    Hanifiha, Melika
    Goodarzi, Azadeh
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [3] Potential effects of curcumin in the treatment ofCOVID-19 infection
    Zahedipour, Fatemeh
    Hosseini, Seyede Atefe
    Sathyapalan, Thozhukat
    Majeed, Muhammed
    Jamialahmadi, Tannaz
    Al-Rasadi, Khalid
    Banach, Maciej
    Sahebkar, Amirhossein
    PHYTOTHERAPY RESEARCH, 2020, 34 (11) : 2911 - 2920
  • [4] Ableism at the Bedside: People with Intellectual Disabilities and COVID-19
    Chicoine, Caitlin
    Hickey, Erin E.
    Kirschner, Kristi L.
    Chicoine, Brian A.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2022, 35 (02) : 390 - 393
  • [5] Self-management interventions for epilepsy in people with intellectual disabilities: A scoping review
    Dannenberg, Michelle
    Mengoni, Silvana E.
    Gates, Bob
    Durand, Marie-Anne
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2016, 41 : 16 - 25
  • [6] Understanding covid-19 outcomes among people with intellectual disabilities in England
    Filip Sosenko
    Daniel Mackay
    Jill P. Pell
    Chris Hatton
    Bhautesh D. Jani
    Deborah Cairns
    Laura Ward
    Angela Henderson
    Michael Fleming
    Dewy Nijhof
    Craig Melville
    BMC Public Health, 23 (1)
  • [7] Understanding covid-19 outcomes among people with intellectual disabilities in England
    Sosenko, Filip
    Mackay, Daniel
    Pell, Jill P.
    Hatton, Chris
    Jani, Bhautesh D.
    Cairns, Deborah
    Ward, Laura
    Henderson, Angela
    Fleming, Michael
    Nijhof, Dewy
    Melville, Craig
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [8] Management and quality indicators of diabetes mellitus in people with intellectual disabilities
    Taggart, L.
    Coates, V.
    Truesdale-Kennedy, M.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2013, 57 (12) : 1152 - 1163
  • [9] Clinical trials for the prevention and treatment ofCOVID-19: current state of play
    Davis, Joshua S.
    Ferreira, David
    Denholm, Justin T.
    Tong, Steven Y. C.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 213 (02) : 86 - 93
  • [10] PTSD and its treatment in people with intellectual disabilities A review of the literature
    Mevissen, L.
    de Jongh, A.
    CLINICAL PSYCHOLOGY REVIEW, 2010, 30 (03) : 308 - 316